Biopharmaceutical Companies’ Personalized Medicine Research Yields Innovative Treatments for Patients
The last five years have been characterized by increased momentum in personalized medicine.
Dr. Tim Garnett, CMO of Eli Lilly and Company, emphasizes that creating lifesaving medicines is the focus of the biopharmaceutical industry.
Codes & Guidelines
Biopharmaceutical companies share with patient organizations a commitment to patients and a mission to discover cures and fight disease.